However, the RPL39L mRNA was also observed outside of the germ cell lineage, particularly in ovarian (12) and breast cancer tissues (2), as well as in lung cancer (13) and neuroblastoma (11) cell lines, where the expression appears to be driven by gene amplifications (14) and CpG island hypomethylation (13). This evidence concerns the gene RPL39L and breast cancer.